SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-034352
Filing Date
2021-02-09
Accepted
2021-02-09 16:14:03
Documents
3
Period of Report
2021-02-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d115818d8k.htm 8-K 27539
2 EX-3.1 d115818dex31.htm EX-3.1 29525
3 EX-3.2 d115818dex32.htm EX-3.2 169874
  Complete submission text file 0001193125-21-034352.txt   228105
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 21606531
SIC: 2834 Pharmaceutical Preparations